immunoglobulin G, human 10 % per 50 ML Injection
- RxCUI
- 1809414
- RxNorm name
- immunoglobulin G, human 10 % per 50 ML Injection
- Display name
- immunoglobulin G, human 10 % per 50 ML Injection
- Full name
- immunoglobulin G, human 10 % per 50 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:15
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125105 | Gammagard Liquid | Immune Globulin Infusion (Human) | 351(a) | Rx | 2026-06-01 |
| 125046 | Gammaked, Gamunex-C | Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified | 351(a) | Rx | 2026-06-01 |
| 125329 | Gammaplex | Immune Globulin Intravenous (Human) | 351(a) | Disc | 2026-06-01 |
| 125062 | Octagam | Immune Globulin Intravenous (Human) | 351(a) | Rx | 2026-06-01 |
| 125389 | Bivigam | Immune Globulin Intravenous (Human) | 351(a) | Rx | 2026-06-01 |
| 125402 | Hyqvia | Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BIVIGAM | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% | ADMA Biologics, Inc. | a2244aa0-a6d0-11df-b385-0002a5d5c51b | 2025-05-05 | Boxed warning, Warnings, Adverse reactions | 1809414 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ade6b84a-e95b-0a49-3296-f56208fdf35b | immunoglobulin G, human 10 % per 50 ML Injection | SY | 37 | These highlights do not include all the information needed to use GAMUNEX ® -C safely and effectively. See full prescribing information for GAMUNEX-C. GAMUNEX ® -C, [Immune Globulin Injection (Human), 10% Caprylate/Chromatography Purified] Initial U.S. Approval: 2003 | 20220429 |
| ade6b84a-e95b-0a49-3296-f56208fdf35b | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 37 | These highlights do not include all the information needed to use GAMUNEX ® -C safely and effectively. See full prescribing information for GAMUNEX-C. GAMUNEX ® -C, [Immune Globulin Injection (Human), 10% Caprylate/Chromatography Purified] Initial U.S. Approval: 2003 | 20220429 |
| ade6b84a-e95b-0a49-3296-f56208fdf35b | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 37 | These highlights do not include all the information needed to use GAMUNEX ® -C safely and effectively. See full prescribing information for GAMUNEX-C. GAMUNEX ® -C, [Immune Globulin Injection (Human), 10% Caprylate/Chromatography Purified] Initial U.S. Approval: 2003 | 20220429 |
| ade6b84a-e95b-0a49-3296-f56208fdf35b | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 37 | These highlights do not include all the information needed to use GAMUNEX ® -C safely and effectively. See full prescribing information for GAMUNEX-C. GAMUNEX ® -C, [Immune Globulin Injection (Human), 10% Caprylate/Chromatography Purified] Initial U.S. Approval: 2003 | 20220429 |
| 8c004331-7a91-8046-7510-9b9b7d33ced7 | immunoglobulin G, human 10 % per 50 ML Injection | SY | 34 | These highlights do not include all the information needed to use GAMMAKED™ safely and effectively. See full prescribing information for GAMMAKED. GAMMAKED™, [Immune Globulin Injection (Human), 10% Caprylate/ Chromatography Purified] Initial U.S. Approval: 2003 | 20200114 |
| 8c004331-7a91-8046-7510-9b9b7d33ced7 | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 34 | These highlights do not include all the information needed to use GAMMAKED™ safely and effectively. See full prescribing information for GAMMAKED. GAMMAKED™, [Immune Globulin Injection (Human), 10% Caprylate/ Chromatography Purified] Initial U.S. Approval: 2003 | 20200114 |
| 8c004331-7a91-8046-7510-9b9b7d33ced7 | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 34 | These highlights do not include all the information needed to use GAMMAKED™ safely and effectively. See full prescribing information for GAMMAKED. GAMMAKED™, [Immune Globulin Injection (Human), 10% Caprylate/ Chromatography Purified] Initial U.S. Approval: 2003 | 20200114 |
| 8c004331-7a91-8046-7510-9b9b7d33ced7 | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 34 | These highlights do not include all the information needed to use GAMMAKED™ safely and effectively. See full prescribing information for GAMMAKED. GAMMAKED™, [Immune Globulin Injection (Human), 10% Caprylate/ Chromatography Purified] Initial U.S. Approval: 2003 | 20200114 |
| 7e5649da-75be-4a42-8eeb-4aeba562c401 | immunoglobulin G, human 10 % per 50 ML Injection | SY | 29 | These highlights do not include all the information needed to use PRIVIGEN safely and effectively. See full prescribing information for PRIVIGEN. PRIVIGEN, Immune Globulin Intravenous (Human), 10% Liquid, for intravenous use Initial U.S. Approval: 2007 | 20260504 |
| 7e5649da-75be-4a42-8eeb-4aeba562c401 | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 29 | These highlights do not include all the information needed to use PRIVIGEN safely and effectively. See full prescribing information for PRIVIGEN. PRIVIGEN, Immune Globulin Intravenous (Human), 10% Liquid, for intravenous use Initial U.S. Approval: 2007 | 20260504 |
| 7e5649da-75be-4a42-8eeb-4aeba562c401 | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 29 | These highlights do not include all the information needed to use PRIVIGEN safely and effectively. See full prescribing information for PRIVIGEN. PRIVIGEN, Immune Globulin Intravenous (Human), 10% Liquid, for intravenous use Initial U.S. Approval: 2007 | 20260504 |
| 7e5649da-75be-4a42-8eeb-4aeba562c401 | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 29 | These highlights do not include all the information needed to use PRIVIGEN safely and effectively. See full prescribing information for PRIVIGEN. PRIVIGEN, Immune Globulin Intravenous (Human), 10% Liquid, for intravenous use Initial U.S. Approval: 2007 | 20260504 |
| 7ca2c26f-4be2-48cd-be5b-486e350654ba | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 22 | These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 2014 | 20260204 |
| 7ca2c26f-4be2-48cd-be5b-486e350654ba | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 22 | These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 2014 | 20260204 |
| 7ca2c26f-4be2-48cd-be5b-486e350654ba | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 22 | These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 2014 | 20260204 |
| 7ca2c26f-4be2-48cd-be5b-486e350654ba | immunoglobulin G, human 10 % per 50 ML Injection | SY | 22 | These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 2014 | 20260204 |
| 9d42adca-0dd7-4df7-864d-5a7feee52130 | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 22 | These highlights do not include all the information needed to use GAMMAGARD LIQUID ® safely and effectively. See full prescribing information for GAMMAGARD LIQUID. GAMMAGARD LIQUID ® , Immune Globulin Infusion (Human), 10% Solution, for intravenous and subcutaneous administration Initial U.S. Approval: 2005 | 20251210 |
| 9d42adca-0dd7-4df7-864d-5a7feee52130 | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 22 | These highlights do not include all the information needed to use GAMMAGARD LIQUID ® safely and effectively. See full prescribing information for GAMMAGARD LIQUID. GAMMAGARD LIQUID ® , Immune Globulin Infusion (Human), 10% Solution, for intravenous and subcutaneous administration Initial U.S. Approval: 2005 | 20251210 |
| 9d42adca-0dd7-4df7-864d-5a7feee52130 | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 22 | These highlights do not include all the information needed to use GAMMAGARD LIQUID ® safely and effectively. See full prescribing information for GAMMAGARD LIQUID. GAMMAGARD LIQUID ® , Immune Globulin Infusion (Human), 10% Solution, for intravenous and subcutaneous administration Initial U.S. Approval: 2005 | 20251210 |
| 9d42adca-0dd7-4df7-864d-5a7feee52130 | immunoglobulin G, human 10 % per 50 ML Injection | SY | 22 | These highlights do not include all the information needed to use GAMMAGARD LIQUID ® safely and effectively. See full prescribing information for GAMMAGARD LIQUID. GAMMAGARD LIQUID ® , Immune Globulin Infusion (Human), 10% Solution, for intravenous and subcutaneous administration Initial U.S. Approval: 2005 | 20251210 |
| a36a12dc-16be-b135-466f-393954f428a7 | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 21 | These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 2014 | 20220408 |
| a36a12dc-16be-b135-466f-393954f428a7 | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 21 | These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 2014 | 20220408 |
| a36a12dc-16be-b135-466f-393954f428a7 | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 21 | These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 2014 | 20220408 |
| a36a12dc-16be-b135-466f-393954f428a7 | immunoglobulin G, human 10 % per 50 ML Injection | SY | 21 | These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 2014 | 20220408 |
| 2098af41-aec7-4af7-98bb-54f8ab55f30e | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 16 | These highlights do not include all the information needed to use GAMMAPLEX ® 10% safely and effectively. See full prescribing information for GAMMAPLEX 10%. GAMMAPLEX 10% Immune Globulin Intravenous [Human], 10% Liquid Initial U.S. Approval: 2017 | 20251023 |
| 2098af41-aec7-4af7-98bb-54f8ab55f30e | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 16 | These highlights do not include all the information needed to use GAMMAPLEX ® 10% safely and effectively. See full prescribing information for GAMMAPLEX 10%. GAMMAPLEX 10% Immune Globulin Intravenous [Human], 10% Liquid Initial U.S. Approval: 2017 | 20251023 |
| 2098af41-aec7-4af7-98bb-54f8ab55f30e | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 16 | These highlights do not include all the information needed to use GAMMAPLEX ® 10% safely and effectively. See full prescribing information for GAMMAPLEX 10%. GAMMAPLEX 10% Immune Globulin Intravenous [Human], 10% Liquid Initial U.S. Approval: 2017 | 20251023 |
| 2098af41-aec7-4af7-98bb-54f8ab55f30e | immunoglobulin G, human 10 % per 50 ML Injection | SY | 16 | These highlights do not include all the information needed to use GAMMAPLEX ® 10% safely and effectively. See full prescribing information for GAMMAPLEX 10%. GAMMAPLEX 10% Immune Globulin Intravenous [Human], 10% Liquid Initial U.S. Approval: 2017 | 20251023 |
| a2244aa0-a6d0-11df-b385-0002a5d5c51b | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 15 | These highlights do not include all the information needed to use BIVIGAM ® safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | 20250505 |
| a2244aa0-a6d0-11df-b385-0002a5d5c51b | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 15 | These highlights do not include all the information needed to use BIVIGAM ® safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | 20250505 |
| a2244aa0-a6d0-11df-b385-0002a5d5c51b | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 15 | These highlights do not include all the information needed to use BIVIGAM ® safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | 20250505 |
| a2244aa0-a6d0-11df-b385-0002a5d5c51b | immunoglobulin G, human 10 % per 50 ML Injection | SY | 15 | These highlights do not include all the information needed to use BIVIGAM ® safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | 20250505 |
| 4fe97dac-d952-40f5-9c6a-67cda048ad8f | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 3 | These highlights do not include all the information needed to use GAMUNEX-C FlexBag safely and effectively. See full prescribing information for GAMUNEX-C FlexBag. GAMUNEX-C FlexBag, [immune globulin injection (human), 10%, caprylate/chromatography purified] for intravenous use. Initial U.S. Approval: 2003 | 20260430 |
| 4fe97dac-d952-40f5-9c6a-67cda048ad8f | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 3 | These highlights do not include all the information needed to use GAMUNEX-C FlexBag safely and effectively. See full prescribing information for GAMUNEX-C FlexBag. GAMUNEX-C FlexBag, [immune globulin injection (human), 10%, caprylate/chromatography purified] for intravenous use. Initial U.S. Approval: 2003 | 20260430 |
| 4fe97dac-d952-40f5-9c6a-67cda048ad8f | immunoglobulin G, human 10 % per 50 ML Injection | SY | 3 | These highlights do not include all the information needed to use GAMUNEX-C FlexBag safely and effectively. See full prescribing information for GAMUNEX-C FlexBag. GAMUNEX-C FlexBag, [immune globulin injection (human), 10%, caprylate/chromatography purified] for intravenous use. Initial U.S. Approval: 2003 | 20260430 |
| 4fe97dac-d952-40f5-9c6a-67cda048ad8f | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 3 | These highlights do not include all the information needed to use GAMUNEX-C FlexBag safely and effectively. See full prescribing information for GAMUNEX-C FlexBag. GAMUNEX-C FlexBag, [immune globulin injection (human), 10%, caprylate/chromatography purified] for intravenous use. Initial U.S. Approval: 2003 | 20260430 |
| 1341fd31-0754-47f0-a4d6-7255056b6541 | immunoglobulin G, human 10 % per 50 ML Injection | SY | 2 | These highlights do not include all the information needed to use GAMMAGARD LIQUID ® ERC safely and effectively. See full prescribing information for GAMMAGARD LIQUID ERC. GAMMAGARD LIQUID ERC [immune globulin infusion (human)] 10% solution for intravenous, or subcutaneous use Initial U.S. Approval: 2025 | 20251030 |
| 1341fd31-0754-47f0-a4d6-7255056b6541 | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 2 | These highlights do not include all the information needed to use GAMMAGARD LIQUID ® ERC safely and effectively. See full prescribing information for GAMMAGARD LIQUID ERC. GAMMAGARD LIQUID ERC [immune globulin infusion (human)] 10% solution for intravenous, or subcutaneous use Initial U.S. Approval: 2025 | 20251030 |
| 1341fd31-0754-47f0-a4d6-7255056b6541 | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 2 | These highlights do not include all the information needed to use GAMMAGARD LIQUID ® ERC safely and effectively. See full prescribing information for GAMMAGARD LIQUID ERC. GAMMAGARD LIQUID ERC [immune globulin infusion (human)] 10% solution for intravenous, or subcutaneous use Initial U.S. Approval: 2025 | 20251030 |
| 1341fd31-0754-47f0-a4d6-7255056b6541 | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 2 | These highlights do not include all the information needed to use GAMMAGARD LIQUID ® ERC safely and effectively. See full prescribing information for GAMMAGARD LIQUID ERC. GAMMAGARD LIQUID ERC [immune globulin infusion (human)] 10% solution for intravenous, or subcutaneous use Initial U.S. Approval: 2025 | 20251030 |
| eb4c342b-122c-0072-1428-1747882e6c00 | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 2 | These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 2014 | 20240126 |
| eb4c342b-122c-0072-1428-1747882e6c00 | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 2 | These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 2014 | 20240126 |
| eb4c342b-122c-0072-1428-1747882e6c00 | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 2 | These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 2014 | 20240126 |
| eb4c342b-122c-0072-1428-1747882e6c00 | immunoglobulin G, human 10 % per 50 ML Injection | SY | 2 | These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 2014 | 20240126 |
| 00dd9bbb-ee8b-f369-8cd1-6ce28925f118 | 50 ML immunoglobulin G, human 100 MG/ML Injection | SCD | 2 | These highlights do not include all the information needed to use BIVIGAM safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | 20160225 |
| 00dd9bbb-ee8b-f369-8cd1-6ce28925f118 | immunoglobulin G, human 10 % per 50 ML Injection | SY | 2 | These highlights do not include all the information needed to use BIVIGAM safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | 20160225 |
| 00dd9bbb-ee8b-f369-8cd1-6ce28925f118 | immunoglobulin G, human 10 % in 50 ML Injection | PSN | 2 | These highlights do not include all the information needed to use BIVIGAM safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | 20160225 |
| 00dd9bbb-ee8b-f369-8cd1-6ce28925f118 | immunoglobulin G, human 5 GM per 50 ML Injection | SY | 2 | These highlights do not include all the information needed to use BIVIGAM safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | 20160225 |